One shot for two viruses? combo COVID-Flu vaccine moves forward
NCT ID NCT06695117
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a single combination vaccine that aims to protect against both COVID-19 and influenza at the same time. About 980 adults aged 50 and older received either the combo shot, a flu shot alone, a COVID-19 shot alone, or both shots separately. Researchers monitored safety and immune responses for 12 months to see if the combo works as well as separate vaccines.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 IMMUNIZATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AES - DRS - Optimal Research Alabama - Huntsville Site Number : 8400006
Huntsville, Alabama, 35802-2568, United States
-
Optimal Research - Texas- Site Number : 8400002
Austin, Texas, 78705, United States
-
Orange Grove Family Practice- Site Number : 8400012
Tucson, Arizona, 85741, United States
-
Simon Williamson Clinic - Birmingham- Site Number : 8400003
Birmingham, Alabama, 35211, United States
-
Synexus Clinical Research - New York- Site Number : 8400007
New York, New York, 10017, United States
-
Synexus Clinical Research - St. Louis- Site Number : 8400010
Creve Coeur, Missouri, 63141, United States
-
Synexus Clinical Research US - Atlanta- Site Number : 8400001
Atlanta, Georgia, 30328, United States
-
Synexus Clinical Research US - Dallas- Site Number : 8400005
Dallas, Texas, 75234, United States
-
Synexus Clinical Research US - San Antonio- Site Number : 8400009
San Antonio, Texas, 78229, United States
-
Synexus Clinical Research US - The Villages- Site Number : 8400011
The Villages, Florida, 32162, United States
-
Synexus Clinical Research- Site Number : 8400004
Chicago, Illinois, 60602, United States
-
Synexus Salt Lake City Site Number : 8400008
Salt Lake City, Utah, 84106, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- MRNA tech takes on the flu: could new shots outsmart seasonal strains?
- One shot for two viruses? new combo vaccine trial shows promise
- New flu vaccine tolerability survey completed with over 1,000 participants
- New mRNA vaccine targets bird flu pandemic threat
- New study monitors flu vaccine safety for seniors in korea
- German flu shot survey aims to boost vaccination rates